Medical
Biogen Idec Inc purchases rights to Eisai Co's Alzheimer's therapies
Biogen Idec, a biotech firm based in Cambridge, Massachusetts, has bought the rights of two experimental therapies for Alzheimer's from Tokyo-based Eisai Co, Bloomberg reported.
Invuity Inc secures $36M in Series E funding round
HealthCare Royalty Partners was the lead investor in the Series E funding round of advanced medical devices maker Invuity Inc which raised $36 million, a statement about the funding said.
Irish drug firm Perrigo picks up Aspen Global products in $51M cash deal
Dublin, Ireland-based over-the-counter (OTC) drug manufacturer Perrigo Company PLC picked up a set of products being marketed in Australia and New Zealand from South African firm Aspen Global Inc in a $51-million cash deal.
Ankur Capital backs three rural startups in India
Mumbai, India-based impact investment fund Ankur Capital shelled out INR50 lakh for a 30% stake in each of the Indian rural startups cloud farm-management systems firm Cropln, home compost company Daily Dump, and eye-care service provider ERC.